cyprotex
the ADME Tox specialists
welcome to cyprotex

Investor News

March 9, 2009 - Notification of final results

Cyprotex (AIM:CRX), the drug discovery technology and information company, will be publishing its final results for the year ended 31 December 2008 on Tuesday 17 March 2009.

Tony Baxter, Chief Executive Officer, and John Dootson, Chief Financial Officer, will be presenting the results to analysts at 10.30 a.m. on Friday 20 March 2009 at the offices of Financial Dynamics, Holborn Gate, 26 Southampton Buildings, London, WC2A 1PB.

Enquiries:

Cyprotex PLC
Dr Anthony Baxter, CEO
Mark Warburton, Company Secretary
Tel: +44 (0)1625 505 100


Noble & Company Limited

John Llewellyn-Lloyd
Sam Reynolds
Tel: +44 (0)20 7763 2200


Financial Dynamics

Ben Brewerton
John Dineen
Tel: +44 (0)20 7831 3113


view all the latest news +
2013 archive +
2012 archive +
2011 archive +
2010 archive +
2009 archive +
2008 archive +
2007 archive +
2006 archive +
2005 archive +
2004 archive +
2003 archive +
2002 archive +
contact

Find out more about us.

Investor Relations
Anthony Baxter/Mark Warburton

Call on +44 1625 505100

contact
careerscontactlegalprivacy
This website was last updated
on 16th April 2014
This website is intended to assist investors, industry participants, customers and employees to understand Cyprotex’s global operations and ambitions.
Certain information and detail is disclosed in the interest of compliance of AIM Rule 26.